Rekah Pharmaceutical Industry Ltd Financial Flexibility Index
Rekah Pharmaceutical Industry Ltd financial flexibility index. Rekah Pharmaceutical Industry Ltd (REKA) has a Financial Flexibility Index of 0.05x as of June 2026. Free cash flow of ILA14.31 Million (operating CF ILA13.82 Million minus capex ILA495.00K) represents 0% of total liabilities (ILA281.29 Million). See Rekah Pharmaceutical Industry Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Rekah Pharmaceutical Industry Ltd (2004–2025)
Financial flexibility index of Rekah Pharmaceutical Industry Ltd from 2004 to 2025. Historical Financial Flexibility Index trend for Rekah Pharmaceutical Industry Ltd across 20 annual periods. Check earnings quality score of Rekah Pharmaceutical Industry Ltd to evaluate the quality of earnings relative to operating cash generation.
Rekah Pharmaceutical Industry Ltd Financial Flexibility Index by Year (2004–2025)
Rekah Pharmaceutical Industry Ltd financial flexibility index by year from 2004 to 2025. Year-by-year free cash flow to debt coverage for Rekah Pharmaceutical Industry Ltd. For the full cash flow conversion analysis, see REKA operating cash flow.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.07x | ILA19.98 Million | ILA12.95 Million | ILA279.47 Million | ▼ -42.1% |
| 2024 | 0.12x | ILA35.24 Million | ILA26.54 Million | ILA285.24 Million | ▲ +2.1% |
| 2023 | 0.12x | ILA39.84 Million | ILA28.35 Million | ILA329.14 Million | ▼ -25.4% |
| 2022 | 0.16x | ILA46.48 Million | ILA39.00 Million | ILA286.34 Million | ▲ +21.9% |
| 2021 | 0.13x | ILA35.16 Million | ILA21.17 Million | ILA264.02 Million | ▲ +12.4% |
| 2020 | 0.12x | ILA30.12 Million | ILA11.28 Million | ILA254.10 Million | ▼ -68.3% |
| 2019 | 0.37x | ILA79.31 Million | ILA33.91 Million | ILA211.89 Million | ▲ +72.5% |
| 2018 | 0.22x | ILA32.46 Million | ILA17.28 Million | ILA149.62 Million | ▼ -19.0% |
| 2017 | 0.27x | ILA40.27 Million | ILA23.80 Million | ILA150.33 Million | ▲ +60.2% |
| 2016 | 0.17x | ILA36.27 Million | ILA22.82 Million | ILA216.86 Million | ▲ +76.6% |
| 2015 | 0.09x | ILA18.95 Million | ILA5.81 Million | ILA200.17 Million | ▲ +7.1% |
| 2014 | 0.09x | ILA20.60 Million | ILA1.33 Million | ILA233.05 Million | ▲ +22.9% |
| 2013 | 0.07x | ILA16.09 Million | ILA11.71 Million | ILA223.65 Million | ▼ -32.0% |
| 2012 | 0.11x | ILA24.00 Million | ILA14.18 Million | ILA226.90 Million | ▲ +62.4% |
| 2010 | 0.07x | ILA14.61 Million | ILA6.73 Million | ILA224.18 Million | ▼ -60.5% |
| 2009 | 0.17x | ILA35.36 Million | ILA26.03 Million | ILA214.25 Million | ▲ +121.2% |
| 2008 | 0.07x | ILA17.30 Million | ILA6.57 Million | ILA231.87 Million | ▼ -1.6% |
| 2007 | 0.08x | ILA17.73 Million | ILA12.45 Million | ILA233.86 Million | ▲ +38.9% |
| 2005 | 0.05x | ILA11.36 Million | ILA4.27 Million | ILA208.15 Million | ▼ -63.0% |
| 2004 | 0.15x | ILA22.57 Million | ILA17.87 Million | ILA153.18 Million | — |